BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15626751)

  • 1. Beta-arrestin-dependent spontaneous alpha1a-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments.
    Pediani JD; Colston JF; Caldwell D; Milligan G; Daly CJ; McGrath JC
    Mol Pharmacol; 2005 Apr; 67(4):992-1004. PubMed ID: 15626751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.
    Stanasila L; Abuin L; Dey J; Cotecchia S
    Mol Pharmacol; 2008 Sep; 74(3):562-73. PubMed ID: 18523139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics.
    Vrecl M; Anderson L; Hanyaloglu A; McGregor AM; Groarke AD; Milligan G; Taylor PL; Eidne KA
    Mol Endocrinol; 1998 Dec; 12(12):1818-29. PubMed ID: 9849957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.
    Mackenzie JF; Daly CJ; Pediani JD; McGrath JC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):434-43. PubMed ID: 10900216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of beta-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization.
    Simaan M; Bédard-Goulet S; Fessart D; Gratton JP; Laporte SA
    Cell Signal; 2005 Sep; 17(9):1074-83. PubMed ID: 15993749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis.
    Liang W; Curran PK; Hoang Q; Moreland RT; Fishman PH
    J Cell Sci; 2004 Feb; 117(Pt 5):723-34. PubMed ID: 14734649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-mediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles.
    Kreuzer OJ; Krisch B; Déry O; Bunnett NW; Meyerhof W
    J Neuroendocrinol; 2001 Mar; 13(3):279-87. PubMed ID: 11207943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular trafficking of human alpha1a-adrenergic receptors is continuous and primarily agonist-independent.
    Morris DP; Price RR; Smith MP; Lei B; Schwinn DA
    Mol Pharmacol; 2004 Oct; 66(4):843-54. PubMed ID: 15258254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
    Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes.
    Chalothorn D; McCune DF; Edelmann SE; García-Cazarín ML; Tsujimoto G; Piascik MT
    Mol Pharmacol; 2002 May; 61(5):1008-16. PubMed ID: 11961118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone receptor recycling: role of receptor dephosphorylation and beta-arrestin.
    Chauvin S; Bencsik M; Bambino T; Nissenson RA
    Mol Endocrinol; 2002 Dec; 16(12):2720-32. PubMed ID: 12456793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
    Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirements of arrestin-3 and clathrin for ligand-dependent and -independent internalization of human G protein-coupled receptor 40.
    Qian J; Wu C; Chen X; Li X; Ying G; Jin L; Ma Q; Li G; Shi Y; Zhang G; Zhou N
    Cell Signal; 2014 Nov; 26(11):2412-23. PubMed ID: 25038452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes.
    DeGraff JL; Gagnon AW; Benovic JL; Orsini MJ
    J Biol Chem; 1999 Apr; 274(16):11253-9. PubMed ID: 10196213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis.
    Smith J; Yu R; Hinkle PM
    Mol Endocrinol; 2001 Sep; 15(9):1539-48. PubMed ID: 11518803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human thyrotropin receptor is predominantly internalized by beta-arrestin 2.
    Frenzel R; Voigt C; Paschke R
    Endocrinology; 2006 Jun; 147(6):3114-22. PubMed ID: 16513835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-arrestins regulate interleukin-8-induced CXCR1 internalization.
    Barlic J; Khandaker MH; Mahon E; Andrews J; DeVries ME; Mitchell GB; Rahimpour R; Tan CM; Ferguson SS; Kelvin DJ
    J Biol Chem; 1999 Jun; 274(23):16287-94. PubMed ID: 10347185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
    Fessart D; Simaan M; Laporte SA
    Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.